About MDacne
MDacne is a Healthcare company based in San Francisco (United States) founded in 2009 by Yoram Harth. Personalized acne treatments are delivered via app-based analysis. MDacne has raised $120 thousand across 1 funding round from investors including Y Combinator. Its website mdacne.com draws about 186 thousand monthly visits. MDacne offers products and services including Customized Treatment Kit and AI Skin Analysis. Its focus areas include Life Sciences, Dermatology, Drugs and Diversified. Its legal entity is MDALGORITHMS INC. Its competitors include Incyte, Formation Bio and Arcutis; 2 of its 3 listed competitors have raised funding.
Company details
MDacne was established in 2009 in San Francisco, United States, focusing on the skincare sector. Skin conditions are analyzed through a mobile app to create custom treatment plans. Kits containing items such as dark spot removers, masks, patches, and cleansers are shipped directly to users. Operations center on personalized dermatological solutions for acne management.
- Headquarters San Francisco, United States
- Founders Yoram Harth
- SectorsHealthcare
- Website category Health
- Email••••••••
- Website mdacne.com
- Social X Facebook Instagram
- Legal Name Mdalgorithms Inc.
- Total Equity Funding$120K (USD)
in 1 rounds
- Latest Funding Round$120K (USD), Seed
Jun 2017
- Investors
Products & Services of MDacne
MDacne offers a comprehensive portfolio of products and services, including Customized Treatment Kit and AI Skin Analysis.
Personalized kit with cream, moisturizer, and cleanser for acne relief.
AI-based assessment via quiz and selfie for tailored skincare advice.
Funding Insights of MDacne
MDacne has successfully raised a total of $120K through 1 strategic funding round. The most recent funding activity was a Seed round of $120 thousand completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $120,000
- Total Rounds 1
- Last Round Seed — $120,000
- First Round $120,000
(Jun 2017)
- Investors Count 1
All 1 funding rounds of MDacne with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2017 | $120,000 | Seed | – | – |
1 investors in total: 1 institutional.
Investors in MDacne
MDacne has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Early-stage startups are accelerated via funding and educational programs. | ycombinator.com | Mountain View, United States |
Investor details for MDacne
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MDacne
2 people are tracked at MDacne (2 in leadership).
| Name | Role | Group |
|---|---|---|
Yoram Harth | Co-Founder | Leadership |
Oded Harth | CEO | Leadership |
Complete people profiles for MDacne
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MDacne
2 dated milestones of MDacne across 8 years, from founding to its latest funding, stage changes and deals.
- Founded MDacne is founded.
- Funding First funding round of $120K.
Competitors of MDacne
MDacne has 3 listed competitors in our database, 2 of them funded. They include Incyte, Formation Bio and Arcutis.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| incyte.com | 1991 | Wilmington, United States | 1,387 | Small molecules are developed for cancer and skin disease treatments. | ||
| formation.bio | 2016 | New York, United States | $608.25M | AI-powered drug discovery platform for various diseases | ||
| arcutis.com | 2016 | Westlake Village, United States | $94.5M | 296 | Immunotherapeutic solutions for dermatological conditions are developed. |
Detailed competitors of MDacne
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of MDacne
The website of MDacne (mdacne.com) receives about 185.9K visits a month and ranks #188,124 among all websites worldwide, #6,047 in Health.
- Monthly visits185.9K
▼ 18% vs previous month
- Unique visitors127.6K
per month
- Global rank#188,124
among all websites
- Category rank#6,047
Health · Health
- Bounce rate47%
- Pages per visit2.5
- Average visit54 sec
- DevicesDesktop 10% · Mobile 90%
Websites whose visitors overlap most with MDacne. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
bhbhealth.com | bhbhealth.com | 100% | #10,509,840 | – | |
| curistrelief.com | 99% | 92.4K | #472,111 | View details | |
pharmica.uk | pharmica.uk | 96% | #86,742 | – | |
philippinemedicalassociation.org | philippinemedicalassociation.org | 92% | #1,273,935 | – | |
| herdin.ph | 92% | 94.6K | #430,952 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 27 similar websites and full traffic analytics for MDacne
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 27 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Dermatology
3 companies that operate in the same segment as MDacne (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Mdacne
Complete news archive for MDacne
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MDacne
MDacne was founded in 2009 and raised its 1st funding round 8 years after it was founded.
MDacne is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
MDacne is a funded company, having raised a total of $120K across 1 funding round to date. The company's 1st funding round was a Seed of $120K, raised on Jun 2017.
MDacne was established in 2009 in San Francisco, United States, focusing on the skincare sector. Skin conditions are analyzed through a mobile app to create custom treatment plans. Kits containing items such as dark spot removers, masks, patches, and cleansers are shipped directly to users. Operations center on personalized dermatological solutions for acne management.
MDacne's top competitors include Formation Bio, Arcutis and Incyte.
MDacne offers Customized Treatment Kit and AI Skin Analysis.
MDacne has 1 investor. Key investors include Y Combinator.
MDacne operates through Mdalgorithms Inc..
The website of MDacne receives about 186 thousand visits a month and ranks #188,124 among all websites worldwide.